PAM50 gene analysis showed that in HR+ breast cancer, HER2-low breast cancer had more expressed ERBB2 and luminal-related genes than HER2-zero breast cancer, but not in TNBC (26). This evidence concerns the gene ERBB2 and breast carcinoma.